China Is Top International Priority For AdvaMed's New Chairman
This article was originally published in PharmAsia News
U.S. medical device association AdvaMed's new chairman, Jim Mazzo, cites regulatory roadblocks in China as the most important international marketing issue facing U.S. device manufacturers
You may also be interested in...
Abbott Medical Optics' chief exec Jim Mazzo is on deck to be the next chairman of AdvaMed, succeeding the outgoing Michael Mussallem
Japan is rolling out a new three-track medical device review system based on the novelty of the product, Japanese device reviewers said last week
A recent meeting between U.S. and Chinese government officials and device industry reps yielded some concessions to opening up China's market, but left many more issues on the table, according to a U.S. industry participant